Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

PD-L1 Checkpoint Blockade Augments Anti-Tumor Immune Response of GD2 or HER2-Bsab Ex Vivo Armed T-Cells (EVAT) Therapy in Osteosarcoma

Jeong A Park, MD PhD, Hong fen Guo, PhD, Hong Xu, PhD, Nai-Kong V. Cheung, MD PhD

Blood (2019) 134 (Supplement_1): 1959.

https://doi.org/10.1182/blood-2019-131325

Published: 2019

Journal Articles

Exceptionally Potent Cytotherapy Using T Cells Armed with Novel Tetravalent Recombinant Bispecific Antibodies Specific for GD2 and HER2

Jeong A Park, MD PhD, Hong Xu, PhD, Brian Santich, PhD, Nai-Kong V. Cheung, MD PhD

Blood (2018) 132 (Supplement 1): 4536.

https://doi.org/10.1182/blood-2018-99-120210

Published: 2018

Journal Articles

Novel Oxidative Phosphorylation Inhibitor IACS-010759 Induces AMPK-Dependent Apoptosis of AML Cells

Haeun Yang, Yoko Tabe, MD PhD, Kazumasa Sekihara, PhD, Kaori Saito, Helen Ma, MS, Vivian Ruvolo, PhD, Junichi Imoto, Kazuho Ikeo, PhD, Kaoru Mogushi, PhD, Masaki Hosoya, Yoshihide Hayashizaki, MD PhD, Yasunari Yamanaka, MD PhD, Takashi Miida, MD PhD, Michael Andreeff, MD PhD, Joseph R Marszalek, PhD, Marina Konopleva, MD PhD

Blood (2017) 130 (Supplement 1): 1245.

https://doi.org/10.1182/blood.V130.Suppl_1.1245.1245

Published: 2017

Journal Articles

Germline ERBB2 Variants Associate with Myeloproliferative Neoplasms

Evan M Braunstein, MDPhD, Donna Marie Williams, PhD, Igor Makhlin, MD, Aparna Pallavajjala, Christopher D Gocke, MD, Nara Sobreira, MD, Kala Visvanathan, MD, Linda Resar, MD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2017) 130 (Supplement 1): 1663.

https://doi.org/10.1182/blood.V130.Suppl_1.1663.1663

Published: 2017

Journal Articles

Comparison of MRD Levels and Gene Expression Patterns in MLL-R Versus Non-MLL Infant ALL

Rosemary Sutton, PhD, Tamara Law, BSc (Hons), Nicola C Venn, BSc (Hons), Carol Wadham, PhD, Emily VA Mould, PhD, Murray D Norris, PhD, Rishi S Kotecha, MB ChB FRACP PhD, Rolf Marschalek, PhD, Claus Meyer, PhD, Luciano Dalla-Pozza, MB BS FRACP, Glenn M Marshall, MBBS, MD FRACP, Richard B Lock, PhD, Toby N. Trahair, MBBS FRACP PhD

Blood (2016) 128 (22): 1740.

https://doi.org/10.1182/blood.V128.22.1740.1740

Published: 2016

Journal Articles

In Vitro Comparison of ADCC and CAR Sensitivity of Adult HER-2+ B-ALL Using the NK-92 Human Cell Line Transduced with a Human CD16 (ADCC) or an Anti-HER2 Chimeric Antigen Receptor (CAR)

Beatrice Clemenceau, PhD, Thierry Guillaume, MD PhD, Nelly Robillard, PhD, Regine Vivien, Pierre Peterlin, MD, Alice Garnier, MD, Marie-Christine Bene, Henri Vié, PhD, Patrice Chevallier, MD PhD

Blood (2016) 128 (22): 5193.

https://doi.org/10.1182/blood.V128.22.5193.5193

Published: 2016

Journal Articles

Use of 2HG Levels in the Serum, Urine, or Bone Marrow to Predict IDH Mutations in Adults with Acute Myeloid Leukemia

Andrew M. Brunner, MD, Donna S Neuberg, ScD, Seth A. Wander, MD PhD, Hossein Sadrzadeh, MD, Karen K. Ballen, MD, Philip C. Amrein, MD, Gabriela S. Hobbs, MD, Yi-Bin Chen, MD, Ashley M. Perry, BS, Christelle Joseph, Meghan E. Burke, Aura Y Ramos, Regina Silver, Ilene Galinsky, ANP, Sophia Adamia, PhD, Darrell Borger, PhD, Anthony J Iafrate, MD PhD, Richard M. Stone, MD, Amir T. Fathi, MD

Blood (2015) 126 (23): 2597.

https://doi.org/10.1182/blood.V126.23.2597.2597

Published: 2015

Journal Articles

A Comparative Oncology Analysis of Canine T-Cell Lymphoma (TCL): Immunohistochemical Study and Next Generation Sequencing for Protein Analysis and Genomic Target Discovery

Athena Kritharis, MD, J. Tyson McDonald, PhD, Afshin Beheshti, PhD, Monika Pilichowska, MD, Kristine Burgess, DVM, MS, Luisel Ricks-Santi, PhD, Elizabeth McNiel, DVM, PhD, Ravi Dashnamoorthy, PhD, Andrew M. Evens, DO, MSc

Blood (2015) 126 (23): 3883.

https://doi.org/10.1182/blood.V126.23.3883.3883

Published: 2015

Journal Articles

Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy

Mathias Lutz, Andrea Worschech, Miriam Alb, Sabine Gahn, Laura Bernhard, Michael Schwab, Stefanie Obermeier, Hermann Einsele, Ulrike Kämmerer, Peter Heuschmann, Erdwine Klinker, Christoph Otto, Stephan Mielke

Blood (2015) 125 (2): 261–272.

https://doi.org/10.1182/blood-2014-09-601302

Published: 2015

Journal Articles

Heatshock Protein (HSP) Family Expression Is Dichotomous and Prognostic in Acute Myelogenous Leukemia (AML)

Steven M. Kornblau, MD, Chenyue W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Trang T Nguyen, Tapan Kadia, MD, Gautam Borthakur, MD, Kevin Coombes, PhD, Amina A Qutub, PhD

Blood (2014) 124 (21): 1026.

https://doi.org/10.1182/blood.V124.21.1026.1026

Published: 2014

Journal Articles

Ectopic Expression of Mir-125a or Mubritinib Treatment of Human Acute Promyelocytic Leukemia t(15; 17) NB4 Cells Containing Epigenitically Silenced Mir-125a Results in Inhibition of Cell Cycle Progression Through Targeting the Erbb2 Pathway.

Melanie Ufkin, Pradeep Sathyanarayana

Blood (2012) 120 (21): 2426.

https://doi.org/10.1182/blood.V120.21.2426.2426

Published: 2012

Journal Articles

Transcriptosome and Phospho-Proteomic Analyses of Erythroblasts Expanded in Vitro From Normal Donors (ND) and From Patients with Polycythemia Vera (PV).

Todd Hricik, BS, Anna Sophia McKenney, MPH, Ross L. Levine, Giulia Federici, MS, Ann Zeuner, PhD, Emanuel F. Petricoin, PhD, Agostino Tafuri, Giuliana Alimena, MD, Valentina Tirelli, MS, Francesca Masiello, MS, Fiorella Ciaffoni, PhD, Anna Rita F Migliaccio, PhD

Blood (2012) 120 (21): 2860.

https://doi.org/10.1182/blood.V120.21.2860.2860

Published: 2012

Journal Articles

The Role of Her2/Neu in ALL: Long Term Clinical Follow-up of Surface-Positive Patients and Induction of NK Cell ADCC by Trastuzumab in Vitro

Sebastian P. Haen, Benjamin J Schmiedel, PhD, Nora Roth, Christoph Faul, MD, Robert Möhle, Marc Schmalzing, MD, Lothar Kanz, MD, Wichard Vogel, MD, Helmut R Salih, MD

Blood (2012) 120 (21): 1421.

https://doi.org/10.1182/blood.V120.21.1421.1421

Published: 2012

Journal Articles

Immune Responses Against the Tumor-Associated Antigens WT1, MUC-1, PRAME and HER2/Neu in 114 Prospectively Screened Healthy Donors: Effects of Gender and Prior Pregnancy and Implications for Immunotherapy

Mathias Lutz, Andrea Worschech, PhD, Sabine Gahn, MLS, Laura Bernhard, MLS, Michael Schwab, MD, Hermann Einsele, MD, Ulrike Kämmerer, PhD, Peter Heuschmann, MD, Erdwine Klinker, MD, Christoph Otto, PhD, Stephan Mielke, MD

Blood (2012) 120 (21): 4115.

https://doi.org/10.1182/blood.V120.21.4115.4115

Published: 2012

Journal Articles

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Patrice Chevallier, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, Sebastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Marie-Christine Bene, Norbert Ifrah, Herve Dombret

Blood (2012) 119 (11): 2474–2477.

https://doi.org/10.1182/blood-2011-11-390781

Published: 2012

Journal Articles

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Cassara Pray, BS, Elyse N. Tomaszewski, BA, Ritesh Rathore, MD, Patricia A. Steele, RN, BSN, Muneer H. Abidi, MD, Lois Ayash, MD, Dana L Schalk, BS, MBA, Karen Myers, BSN, OCN, Alice Mitchell, BS, Abhinav Deol, MD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Lawrence G Lum, MD, DSc

Blood (2011) 118 (21): 1914.

https://doi.org/10.1182/blood.V118.21.1914.1914

Published: 2011

Journal Articles

Combining Oncolytic Vaccinia Virotherapy with Adoptive T Cell Therapy,

Minhtran Charlotte Ngo, Jun Ando, MD, PhD, Ann M. Leen, PhD, Caroline Breitbach, PhD, Anne Moon, David Kirn, MD, John Bell, PhD, Cliona M. Rooney, PhD

Blood (2011) 118 (21): 4042.

https://doi.org/10.1182/blood.V118.21.4042.4042

Published: 2011

Journal Articles

Small Molecule Inhibitors of HER2 Inhibit Proliferative Signaling and Promote Apoptosis in Ph+ ALL

Mary E Irwin, PhD, Laura Nelson, PhD, Janice M Santiago-O'Farrill, Claudia P Miller, PhD, Doris R. Siwak, PhD, Gordon B. Mills, MD, PhD, Shulin Li, PhD, Dennis P Hughes, MD, PhD, Joya Chandra, PhD

Blood (2011) 118 (21): 1397.

https://doi.org/10.1182/blood.V118.21.1397.1397

Published: 2011

Journal Articles

Absence of Functional Epo Receptors In Normal and Cancerous Human Tissues and Cell Lines,

Steve Elliott, Susan Swift, Leigh Busse, John M Rossi, Ian McCaffery

Blood (2011) 118 (21): 3169.

https://doi.org/10.1182/blood.V118.21.3169.3169

Published: 2011

Journal Articles

Redirected tumor-specific allogeneic T cells for universal treatment of cancer

Assaf Marcus, Tova Waks, Zelig Eshhar

Blood (2011) 118 (4): 975–983.

https://doi.org/10.1182/blood-2011-02-334284

Published: 2011

Includes: Supplemental data

NARROW

PD-L1 Checkpoint Blockade Augments Anti-Tumor Immune Response of GD2 or HER2-Bsab Ex Vivo Armed T-Cells (EVAT) Therapy in Osteosarcoma

Exceptionally Potent Cytotherapy Using T Cells Armed with Novel Tetravalent Recombinant Bispecific Antibodies Specific for GD2 and HER2

Novel Oxidative Phosphorylation Inhibitor IACS-010759 Induces AMPK-Dependent Apoptosis of AML Cells

Germline ERBB2 Variants Associate with Myeloproliferative Neoplasms

Comparison of MRD Levels and Gene Expression Patterns in MLL-R Versus Non-MLL Infant ALL

In Vitro Comparison of ADCC and CAR Sensitivity of Adult HER-2+ B-ALL Using the NK-92 Human Cell Line Transduced with a Human CD16 (ADCC) or an Anti-HER2 Chimeric Antigen Receptor (CAR)

Use of 2HG Levels in the Serum, Urine, or Bone Marrow to Predict IDH Mutations in Adults with Acute Myeloid Leukemia

A Comparative Oncology Analysis of Canine T-Cell Lymphoma (TCL): Immunohistochemical Study and Next Generation Sequencing for Protein Analysis and Genomic Target Discovery

Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy

Heatshock Protein (HSP) Family Expression Is Dichotomous and Prognostic in Acute Myelogenous Leukemia (AML)

Ectopic Expression of Mir-125a or Mubritinib Treatment of Human Acute Promyelocytic Leukemia t(15; 17) NB4 Cells Containing Epigenitically Silenced Mir-125a Results in Inhibition of Cell Cycle Progression Through Targeting the Erbb2 Pathway.

Transcriptosome and Phospho-Proteomic Analyses of Erythroblasts Expanded in Vitro From Normal Donors (ND) and From Patients with Polycythemia Vera (PV).

The Role of Her2/Neu in ALL: Long Term Clinical Follow-up of Surface-Positive Patients and Induction of NK Cell ADCC by Trastuzumab in Vitro

Immune Responses Against the Tumor-Associated Antigens WT1, MUC-1, PRAME and HER2/Neu in 114 Prospectively Screened Healthy Donors: Effects of Gender and Prior Pregnancy and Implications for Immunotherapy

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

Combining Oncolytic Vaccinia Virotherapy with Adoptive T Cell Therapy,

Small Molecule Inhibitors of HER2 Inhibit Proliferative Signaling and Promote Apoptosis in Ph+ ALL

Absence of Functional Epo Receptors In Normal and Cancerous Human Tissues and Cell Lines,

Redirected tumor-specific allogeneic T cells for universal treatment of cancer

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only